Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication

Journal of Virology

Volumn 88, Issue 19, 2014, Pages 11369-11382

  Gong, Danyang ^a   Wu, Nicholas C ^a   Xie, Yafang ^a   Feng, Jun ^a   Tong, Leming ^a   Brulois, Kevin F ^c   Luan, Harding ^a   Du, Yushen ^a   Jung, Jae U ^c   Wang, Cun Yu ^b   Kang, Mo Kwan ^b   Park, No Hee ^b   Sun, Ren ^a   Wu, Ting Ting ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; DNA REPLICATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IN VITRO STUDY; KERATINOCYTE; MUTAGENESIS; NONHUMAN; ORF18 GENE; ORF30 GENE; RNA SEQUENCE; VIRUS GENE; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION; CELL LINE; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; MOLECULAR GENETICS; MOUTH MUCOSA; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PATHOLOGY; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS ACTIVATION;

BASE SEQUENCE; CELL LINE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KERATINOCYTES; MOLECULAR SEQUENCE DATA; MOUTH MUCOSA; OPEN READING FRAMES; SEQUENCE DELETION; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 84906985212     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00793-14     Document Type: Article

References (55)

1. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191. http://dx .doi.org/10.1056/NEJM199505043321802.
2. Boshoff C, Weiss R. 2002. AIDS-related malignancies. Nat. Rev. Cancer 2:373-382. http://dx.doi.org/10.1038/nrc797.
3. Corbellino M, Poirel L, Aubin JT, Paulli M, Magrini U, Bestetti G, Galli M, Parravicini C. 1996. The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease). Clin. Infect. Dis. 22:1120-1121. http://dx.doi.org/10.1093 /clinids/22.6.1120.
4. Boldogh I, Szaniszlo P, Bresnahan WA, Flaitz CM, Nichols MC, Albrecht T. 1996. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin. Infect. Dis. 23:406-407. http://dx.doi.org/10.1093/clinids/23.2.406.
5. Koelle DM, Huang ML, Chandran B, Vieira J, Piepkorn M, Corey L. 1997. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virusinfected men: clinical and immunologic correlates. J. Infect. Dis. 176:94-102. http://dx.doi.org/10.1086/514045.
6. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. 2000. Mucosal shedding of human herpesvirus 8 in men. N. Engl. J. Med. 343:1369 -1377. http://dx.doi.org /10.1056/NEJM200011093431904.
7. Vieira J, Huang ML, Koelle DM, Corey L. 1997. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J. Virol. 71:7083-7087.
8. de Franca TR, de Araujo RA, Ribeiro CM, Leao JC. 2011. Salivary shedding of HHV-8 in people infected or not by human immunodeficiency virus 1. J. Oral Pathol. Med. 40:97-102. http://dx.doi.org/10.1111 /j.1600-0714.2010.00959.x.
9. Duus KM, Lentchitsky V, Wagenaar T, Grose C, Webster-Cyriaque J. 2004. Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J. Virol. 78:4074-4084. http://dx.doi.org/10 .1128/JVI.78.8.4074-4084.2004.
10. Johnson AS, Maronian N, Vieira J. 2005. Activation of Kaposi's sarcomaassociated herpesvirus lytic gene expression during epithelial differentiation. J. Virol. 79:13769-13777. http://dx.doi.org/10.1128/JVI.79.21.13769-13777.2005.
11. Thompson MP, Kurzrock R. 2004. Epstein-Barr virus and cancer. Clin. Cancer Res. 10:803-821. http://dx.doi.org/10.1158/1078-0432.CCR-0670-3.
12. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. 1984. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310:1225-1230. http://dx.doi.org/10.1056/NEJM198405103101905.
13. Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA. 2009. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog. 5:e1000496. http://dx.doi.org/10 .1371/journal.ppat.1000496.
14. Wong E, Wu TT, Reyes N, Deng H, Sun R. 2007. Murine gammaherpesvirus 68 open reading frame 24 is required for late gene expression after DNA replication. J. Virol. 81:6761-6764. http://dx.doi.org/10.1128/JVI .02726-06.
15. Arumugaswami V, Wu TT, Martinez-Guzman D, Jia Q, Deng H, Reyes N, Sun R. 2006. ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J. Virol. 80:9730-9740. http://dx .doi.org/10.1128/JVI.00246-06.
16. Wu TT, Park T, Kim H, Tran T, Tong L, Martinez-Guzman D, Reyes N, Deng H, Sun R. 2009. ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J. Virol. 83:2265-2273. http://dx.doi.org/10.1128/JVI.01785-08.
17. Jia Q, Wu TT, Liao HI, Chernishof V, Sun R. 2004. Murine gammaherpesvirus 68 open reading frame 31 is required for viral replication. J. Virol. 78:6610-6620. http://dx.doi.org/10.1128/JVI.78.12.6610-6620.2004.
18. Omoto S, Mocarski ES. 2013. Cytomegalovirus UL91 is essential for transcription of viral true late (gamma 2) genes J. Virol. 87:8651-8664. http://dx.doi.org/10.1128/JVI.01052-13.
19. Isomura H, Stinski MF, Murata T, Yamashita Y, Kanda T, Toyokuni S, Tsurumi T. 2011. The human cytomegalovirus gene products essential for late viral gene expression assemble into prereplication complexes before viral DNA replication. J. Virol. 85:6629-6644. http://dx.doi.org/10.1128 /JVI.00384-11.
20. Omoto S, Mocarski ES. 2014. Transcription of true late (2) cytomegalovirus genes requires UL92 function that is conserved among beta-and gammaherpesviruses. J. Virol. 88:120-130. http://dx.doi.org/10.1128/JVI .02983-13.
21. Chapa TJ, Perng YC, French AR, Yu D. 2014. Murine cytomegalovirus protein pM92 is a conserved regulator of viral late gene expression. J. Virol. 88:131-142. http://dx.doi.org/10.1128/JVI.02684-13.
22. Chapa TJ, Johnson LS, Affolter C, Valentine MC, Fehr AR, Yokoyama WM, Yu D. 2013. Murine cytomegalovirus protein pM79 is a key regulator for viral late transcription. J. Virol. 87:9135-9147. http://dx.doi.org /10.1128/JVI.00688-13.
23. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU. 2012. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J. Virol. 86:9708-9720. http://dx.doi.org/10.1128/JVI.01019-12.
24. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J. Virol. Methods 174:12-21. http: //dx.doi.org/10.1016/j.jviromet.2011.03.012.
25. Park NH, Min BM, Li SL, Huang MZ, Cherick HM, Doniger J. 1991. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 12:1627-1631. http://dx.doi.org/10.1093 /carcin/12.9.1627.
26. Tischer BK, Smith GA, Osterrieder N. 2010. En passant mutagenesis: a two step markerless red recombination system. Methods Mol. Biol. 634: 421-430. http://dx.doi.org/10.1007/978-1-60761-652-8_30.
27. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111. http://dx.doi.org /10.1093/bioinformatics/btp120.
28. Cerimele F, Curreli F, Ely S, Friedman-Kien AE, Cesarman E, Flore O. 2001. Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J. Virol. 75:2435-2443. http://dx.doi.org/10.1128/JVI.75.5.2435-2443.2001.
29. Lagunoff M, Bechtel J, Venetsanakos E, Roy AM, Abbey N, Herndier B, McMahon M, Ganem D. 2002. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J. Virol. 76:2440-2448. http://dx.doi.org/10.1128/jvi.76.5.2440-2448.2002.
30. Schulz TF, Chang Y. 2007. KSHV gene expression and regulation, chapter 28. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K(ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom. http://www.ncbi.nlm.nih.gov/books/NBK47415/.
31. Bala K, Bosco R, Gramolelli S, Haas DA, Kati S, Pietrek M, Havemeier A, Yakushko Y, Singh VV, Dittrich-Breiholz O, Kracht M, Schulz TF. 2012. Kaposi's sarcoma herpesvirus K15 protein contributes to virusinduced angiogenesis by recruiting PLCgamma1 and activating NFAT1-dependent RCAN1 expression. PLoS Pathog. 8:e1002927. http://dx.doi .org/10.1371/journal.ppat.1002927.
32. Spiller OB, Robinson M, O'Donnell E, Milligan S, Morgan BP, Davison AJ, Blackbourn DJ. 2003. Complement regulation by Kaposi's sarcomaassociated herpesvirus ORF4 protein. J. Virol. 77:592-599. http://dx.doi .org/10.1128/JVI.77.1.592-599.2003.
33. Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. 1997. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15:1979-1985. http://dx.doi.org/10.1038/sj .onc.1201571.
34. Coscoy L. 2007. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat. Rev. Immunol. 7:391-401. http://dx.doi.org/10.1038/nri2076.
35. Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU. 2010. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol. 5:1349-1365. http://dx.doi.org/10.2217/fmb.10.105.
36. Gao SJ, Deng JH, Zhou FC. 2003. Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J. Virol. 77:9738-9749. http://dx.doi.org/10.1128/JVI.77.18.9738-9749.2003.
37. Hassman LM, Ellison TJ, Kedes DH. 2011. KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J. Clin. Invest. 121:752-768. http://dx.doi.org/10.1172/JCI44185.
38. Bechtel JT, Liang Y, Hvidding J, Ganem D. 2003. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 77:6474-6481. http://dx.doi.org/10.1128/JVI.77.11.6474-6481.2003.
39. Wu W, Vieira J, Fiore N, Banerjee P, Sieburg M, Rochford R, Harrington W, Jr, Feuer G. 2006. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34 ) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood 108:141-151. http://dx.doi.org/10 .1182/blood-2005-04-1697.
40. Blackbourn DJ, Lennette E, Klencke B, Moses A, Chandran B, Weinstein M, Glogau RG, Witte MH, Way DL, Kutzkey T, Herndier B, Levy JA. 2000. The restricted cellular host range of human herpesvirus 8. AIDS 14:1123-1133. http://dx.doi.org/10.1097/00002030-200006160-00009.
41. Ji S, Kim Y, Min BM, Han SH, Choi Y. 2007. Innate immune responses of gingival epithelial cells to nonperiodontopathic and periodontopathic bacteria. J. Periodontal Res. 42:503-510. http://dx.doi.org/10.1111/j.1600-0765.2007.00974.x.
42. Shin JE, Baek KJ, Choi YS, Choi Y. 2013. A periodontal pathogen Treponema denticola hijacks the Fusobacterium nucleatum-driven host response. Immunol. Cell Biol. 91:503-510. http://dx.doi.org/10.1038/icb .2013.35.
43. Shin JE, Choi Y. 2010. Treponema denticola suppresses expression of human beta-defensin-2 in gingival epithelial cells through inhibition of TNFalpha production and TLR2 activation. Mol. Cells 29:407-412. http: //dx.doi.org/10.1007/s10059-010-0048-5.
44. Huang GT, Zhang X, Park NH. 2000. Increased ICAM-1 expression in transformed human oral epithelial cells: molecular mechanism and functional role in peripheral blood mononuclear cell adhesion and lymphokine-activated-killer cell cytotoxicity. Int. J. Oncol. 17:479-486. http://dx .doi.org/10.3892/ijo.17.3.479.
45. Park NH, Gujuluva CN, Baek JH, Cherrick HM, Shin KH, Min BM. 1995. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 10:2145-2153.
46. Vigneswaran N, Baucum DC, Wu J, Lou Y, Bouquot J, Muller S, Zacharias W. 2007. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression. BMCCancer 7:108. http://dx.doi.org/10.1186/1471-2407-7-108.
47. Rey O, Baluda MA, Park NH. 1999. Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes. Oncogene 18:827-831. http://dx.doi.org/10.1038/sj.onc.1202328.
48. Oh KJ, Kalinina A, Park NH, Bagchi S. 2006. Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein. J. Virol. 80:7079-7088. http://dx.doi.org/10.1128/JVI.02380-05.
49. Oh JE, Kim RH, Shin KH, Park NH, Kang MK. 2011. DeltaNp63alpha protein triggers epithelial-mesenchymal transition and confers stem cell properties in normal human keratinocytes. J. Biol. Chem. 286:38757-38767. http://dx.doi.org/10.1074/jbc.M111.244939.
50. Hong Y, Qi J, Gong D, Han C, Deng H. 2011. Replication and transcription activator (RTA) of murine gammaherpesvirus 68 binds to an RTA-responsive element and activates the expression of ORF18. J. Virol. 85:11338-11350. http://dx.doi.org/10.1128/JVI.00561-11.
51. Wyrwicz LS, Rychlewski L. 2007. Identification of herpes TATT-binding protein. Antiviral Res. 75:167-172. http://dx.doi.org/10.1016/j.antiviral.2007.03.002.
52. Gruffat H, Kadjouf F, Mariame B, Manet E. 2012. The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression. J. Virol. 86:6023-6032. http://dx.doi.org/10.1128/JVI.00159-12.
53. Wong-Ho E, Wu TT, Davis ZH, Zhang B, Huang J, Gong H, Deng H, Liu F, Glaunsinger B, Sun R. 2014. Unconventional sequence requirement for viral late gene core promoters of murine gammaherpesvirus 68. J. Virol. 88:3411-3422. http://dx.doi.org/10.1128/JVI.01374-13.
54. Serio TR, Cahill N, Prout ME, Miller G. 1998. A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle. J. Virol. 72:8338-8343.
55. Amon W, Binne UK, Bryant H, Jenkins PJ, Karstegl CE, Farrell PJ. 2004. Lytic cycle gene regulation of Epstein-Barr virus. J. Virol. 78:13460-13469. http://dx.doi.org/10.1128/JVI.78.24.13460-13469.2004.